Cargando…
Onset of spondyloarthritis in a patient treated with adalimumab for relapsing anterior uveitis – efficacy of secukinumab on the joint domain and on ocular inflammatory relapses: A case report
Adalimumab, an inhibitor of tumor necrosis factor-alpha, is a systemic non-corticosteroid agent approved for the treatment of noninfectious uveitis. Secukinumab, a human monoclonal antibody inhibiting interleukin 17A, is also being investigated as a potential treatment for noninfectious uveitis. PAT...
Autor principal: | Raimondo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704995/ https://www.ncbi.nlm.nih.gov/pubmed/36451402 http://dx.doi.org/10.1097/MD.0000000000031554 |
Ejemplares similares
-
Risk factors associated with relapse of adult-onset Still disease in Korean patients
por: Kang, Ji-Hyoun
Publicado: (2020) -
Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort
por: Cantarini, Luca, et al.
Publicado: (2015) -
Mechanical model of steady-state and inflammatory conditions in patients with relapsing polychondritis: A review
por: Shimizu, Jun, et al.
Publicado: (2022) -
Meningoencephalitis in relapsing polychondritis: A case report
por: Matsumoto, Haruki, et al.
Publicado: (2021) -
Clinical, histological features, and predictors of relapse in patients with idiopathic granulomatous mastitis
por: Abbi, Bhavna, et al.
Publicado: (2023)